AYUSH- 64: A potential therapeutic agent in COVID-19

AYUSH- 64: A potential therapeutic agent in COVID-19

Corona Virus disease (COVID-19) has become a global pandemic resulting in large scale morbidity and mortality worldwide. The management of COVID-19 has been a big challenge because of multifactorial pathophysiology and no specific treatment. AYUSH-64, a poly-herbal formulation developed by CCRAS, Mi...

Full description

Bibliographic Details
Main Authors:	Ashok Kumar Panda, Sarbeswar Kar, Amit Kumar Rai, B.C.S. Rao, N. Srikanth
Format:	Article
Language:	English
Published:	Elsevier 2022-04-01
Series:	Journal of Ayurveda and Integrative Medicine
Subjects:	AYUSH-64 COVID-19 Corona virus disease Immunomodulation SARS-CoV-2 Ayurveda
Online Access:	http://www.sciencedirect.com/science/article/pii/S0975947621002278

Similar Items

Efficacy and safety of AYUSH-64 as standalone or adjunct to standard care in COVID-19: a structured summary of protocol for a systematic review
by: Amit Kumar Rai, et al.
Published: (2022-05-01)

Evaluating therapeutic potential of AYUSH-64 constituents against omicron variant of SARS-CoV-2 using ensemble docking and simulations
by: Vinod Jani, et al.
Published: (2024-01-01)

Disease Characteristics, Care-Seeking Behavior, and Outcomes Associated With the Use of AYUSH-64 in COVID-19 Patients in Home Isolation in India: A Community-Based Cross-Sectional Analysis
by: Narayanam Srikanth, et al.
Published: (2022-07-01)

Impact of AYUSH 64 as an adjunctive to standard of care in mild COVID 19 - An open-label randomized controlled pilot study
by: Anup Thakar, et al.
Published: (2022-07-01)

AYUSH 64, a polyherbal Ayurvedic formulation in Influenza-like illness - Results of a pilot study
by: Manohar S. Gundeti, et al.
Published: (2022-01-01)

Immunity against COVID-19: Potential role of Ayush Kwath
by: Shankar Gautam, et al.
Published: (2022-01-01)

In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease
by: Thrigulla Saketh Ram, et al.
Published: (2022-01-01)

Randomized double blind placebo controlled multicentric clinical trial of Ayush M-3 in the management of migraine- A study protocol
by: Shweta Chaudhary, et al.
Published: (2025-03-01)

Advancing the one health approach through integration of Ayush systems: Opportunities and way forward
by: Shobhit Kumar, et al.
Published: (2023-09-01)

AYUSH digital initiatives: Harnessing the power of digital technology for India’s traditional medical systems
by: Sendhilkumar Muthappan, et al.
Published: (2022-04-01)

In silico exploration of phytocompounds from AYUSH-64 medicinal plants against SARS CoV-2 RNA-dependent RNA polymerase
by: Srinivasulu Cheemanapalli, et al.
Published: (2024-11-01)

Beneficial role of Indian medicinal plants in COVID-19
by: Deepti Chopra, et al.
Published: (2021-01-01)

Management approach to Covid-19 associated upper respiratory tract infection in Ayurveda: A review study
by: Gulab Chand Pamnani, et al.
Published: (2020-01-01)

Practices at an AYUSH health camp for asthma in Pendra, Chhattisgarh
by: Raghavendra Madhu
Published: (2011-01-01)

Evaluation of Ayush-64 (a Polyherbal Formulation) and Its Ingredients in the Syrian Hamster Model for SARS-CoV-2 Infection Reveals the Preventative Potential of <i>Alstonia scholaris</i>
by: Zaigham Abbas Rizvi, et al.
Published: (2023-09-01)

Report: Council for Ayurveda Research - Industry Roundtable and Global Consortium for Collaborative Research in Ayurveda, 2021
by: Pratibha Shah, et al.
Published: (2022-07-01)

AYUSH'u Hindistan'ın sağlık dağıtım sistemine entegre etmek
by: Saurabh Shrivastava, et al.
Published: (2019-12-01)

Effect of Ayurveda and Siddha interventions in the management of chronic lymphocytic leukemia: A case report
by: Abhay Kumar Prajapati, et al.
Published: (2025-01-01)

Evidence Based Validation of Indian Traditional Medicine – Way Forward
by: Pulok K Mukherjee, et al.
Published: (2016-01-01)

Jatharagni and Prakriti of young Indian adult population: A descriptive cross-sectional study
by: Meera Kuttikrishnan, et al.
Published: (2022-01-01)

Sensitization of population for preventive measures suggested by AYUSH ministry through development of mobile application “virtual immunity booster:” A prototype research model
by: Danish Javed, et al.
Published: (2023-01-01)

A critical analysis of CTRI registered AYUSH studies for COVID- 19
by: Vedvati Bhapkar, et al.
Published: (2022-01-01)

Assessment Of Knowledge and Performance of Ayush Doctors Posted in Collocation Under National Rural Health Mission in Udaipur Division, Rajasthan
by: Arun Kumar, et al.
Published: (2013-12-01)

Strengthening AYUSH Integration with Preventive Medicine
by: Vartika Saxena, et al.
Published: (2024-12-01)

Perception on effect of AYUSH treatment among patients with selected NCDs at life style diseases clinics from six states of India: Lessons learnt and way forward
by: T P Sherin Raj, et al.
Published: (2023-01-01)

Network pharmacology of AYUSH recommended immune-boosting medicinal plants against COVID-19
by: Pukar Khanal, et al.
Published: (2022-01-01)

Prevalence and correlates of multimorbidity among patients attending AYUSH primary care settings in Delhi-National Capital Region, India
by: Roja Varanasi, et al.
Published: (2023-11-01)

AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India
by: Harbans Singh, et al.
Published: (2022-06-01)

Knowledge and Practice Regarding Prevention and Management of Rabies among Allopathic and Ayush Private Practitioners in Urban Maharashtra: A Comparison Study
by: Shubhalaxmi D Kotnis, et al.
Published: (2017-04-01)

Ratrijagarana night wakefulness and its impact on Manasika Bhava mental characteristics among industrial workers: A descriptive cross-sectional study
by: Elgeena Varghese, et al.
Published: (2022-04-01)

Relevance of Traditional Indian Medical Concepts in Psychosomatic Medicine
by: Mamta Sood, et al.
Published: (2017-07-01)

An Evaluation on Medical Education, Research and Development of AYUSH Systems of Medicine through Five Year Plans of India
by: JANMEJAYA SAMAL, et al.
Published: (2016-05-01)

Analysis of AYUSH studies registered in clinical trials registry of India from 2009 to 2020
by: M.S. Shree Devi, et al.
Published: (2021-04-01)

Dissociated reality vis-a-vis integrative planning of AYUSH in Maternal Health Program: A situational analysis in Jaleswar block of Balasore district of Odisha, India
by: Ranjit Kumar Dehury, et al.
Published: (2016-04-01)

All India AYUSH post graduate entrance exam 2019 – AYURVEDA MCQ item analysis
by: Shivakumar Harti, et al.
Published: (2021-04-01)

Unit costs for allopathic and AYUSH outpatient care in public facilities in Urban Delhi, India
by: Charu C. Garg, et al.
Published: (2023-11-01)

In vitro effect of Withania somnifera, AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb−drug interactions in the management of COVID-19
by: Siva Swapna Kasarla, et al.
Published: (2022-10-01)

An Up-to-Date Overview of Therapeutic Agents for the Treatment of COVID-19 Disease
by: Mulaw Belete T
Published: (2020-12-01)

More Accurate Differential Properties of LED64 and Midori64
by: Ling Sun, et al.
Published: (2018-09-01)

Population-based Research in AYUSH: Lessons from Study among Particularly Vulnerable Tribal Groups to Determine Burden of Sickle Cell Disorders
by: Nisanth K. M. Nambison, et al.
Published: (2024-11-01)